Related Experiment Video
Updated: Feb 4, 2026

Individualized Stem-positioning in Calcar-guided Short-stem Total Hip Arthroplasty
Published on: February 27, 2018
Total hip arthroplasty outcomes in morbidly obese patients: A systematic review
Matthew Barrett1, Anoop Prasad2, Louis Boyce1
1Barts and the London School of Medicine & Dentistry, UK.
Insights
Morbidly obese patients undergoing total hip arthroplasty (THA) have a slightly higher revision rate but comparable functional outcomes to non-obese patients. Patients should be informed of these risks and benefits before surgery.
Area of Science:
- Orthopedic Surgery
- Obesity Medicine
- Biostatistics
Background:
- Rising obesity rates increase the number of total hip arthroplasties (THAs) performed on high body mass index (BMI) patients.
- THA in morbidly obese individuals presents surgical challenges due to comorbidities and anatomical factors.
- Long-term outcomes of THA in morbidly obese patients remain unclear.
Purpose of the Study:
- To systematically review and compare the long-term failure rates and functional outcomes of THA in morbidly obese versus non-obese patients.
- To assess the impact of high BMI on revision rates and patient function after THA.
Main Methods:
- A systematic literature search was conducted on PubMed, EMBASE, and PubMed Central.
- Studies comparing THA outcomes in morbidly obese patients (BMI ≥ 35) to controls (BMI < 30) were included.
- Primary outcome: long-term revision rate; Secondary outcome: long-term functional outcome.
Main Results:
- Eight studies involving 66,238 THAs in morbidly obese patients and 705,619 in non-obese patients were analyzed.
- The overall revision rate was 7.99% in morbidly obese patients compared to 2.75% in non-obese controls.
- Functional outcomes were comparable between morbidly obese and non-obese patient groups.
Conclusions:
- Morbidly obese patients experience a slightly elevated revision rate after THA.
- Despite increased revision risk, functional recovery in morbidly obese patients is comparable to non-obese individuals.
- Informed consent regarding these specific outcomes is crucial for morbidly obese patients considering THA.
Abstract:
The increasing prevalence of obesity has resulted in a marked increase in the number of total hip arthroplasties (THAs) carried out in patients with a high body mass index (BMI).THA in morbidly obese patients is often technically challenging owing to the associated co-morbidities and anatomical factors. Furthermore, the long-term clinical and functional outcomes of the procedure in these patients are not clear.The aim of this systematic review was to compare the long-term failure rate and functional outcomes of THA in morbidly obese versus non-obese patients.A literature search of PubMed, EMBASE and PubMed Central was conducted to identify studies that compared the outcomes of THA in patients defined as morbidly obese (BMI ≥ 35) to a control group (BMI < 30). The primary and secondary outcome measures were rate of revision and functional outcome, respectively, in the long term.Eight studies were included in this review. There were 66,238 THAs in morbidly obese patients and 705,619 THAs in patients with a BMI < 30. The overall revision rate was 7.99% in the morbidly obese patients versus 2.75% in the non-obese controls. The functional outcome was at least comparable to non-obese patients.This review suggests that morbidly obese patients have a slightly increased revision rate following THA. Importantly, these patients have a functional recovery at least comparable to those with a BMI < 30. Morbidly obese patients should be fully informed of these issues prior to undergoing surgery. Cite this article: EFORT Open Rev 2018;3:507-512. DOI: 10.1302/2058-5241.3.180011.
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview

